Skip to Content
Merck
CN

17-500M

Catch and Release v2.0 Reversible Immunoprecipitation System

Synonym(s):

Catch and release system, Immunoprecipitation kit

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

UNSPSC Code:
12161503
NACRES:
NB.22
eCl@ss:
32161000
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

species reactivity (predicted by homology)

all

manufacturer/tradename

Catch And Release, Upstate®

technique(s)

activity assay: suitable (IP-kinase), immunoprecipitation (IP): suitable, western blot: suitable

shipped in

wet ice

Quality Level

General description

Features & Benefits:
Reproducible: eliminates aspiration steps that typically lead to diminished/lost sample
Convenient: spin-column format dramatically simplifies sample handling
Reversible: simple elution of antigen:antibody complex in either native or denatured form



Use:
This kit allows for quick and reproducible immunoprecipitation (IP) by using a spin column. The system is more reproducible than regular IP′s, which are problematic with regards to washing the protein A/G agarose without disrupting the agarose bed. The binding of the antibody/antigen complex in Catch and Release is reversible, and elution of the immune complex can occur with native or denaturing buffers. The system has been tested successfully with rabbit, mouse, sheep and goat antibodies. IP using human IgG1-4 should be suitable. IP using chicken antibodies or human IgA, IgD, IgE or IgM is not recommended with this kit. Please read the enclosed product manual before use.

Application

Catch and Release v2.0 should not be used with proteins containing a 6-His tag.

Packaging

17-500A is supplied as 5 immunoprecipitations per kit.
17-500 is supplied as 50 immunoprecipitations per kit.

Preparation Note

All components to be stored at 4°C except the Catch and Release Capture Tubes which are stored at room temperature. Components are stable for 6 months from date of shipment.

Analysis Note

routinely evaluated by immunoprecipitation.

Other Notes

Catch and Release Wash Buffer, 10X

Catch and Release Non-denaturing Elution Buffer, 4X

Catch and Release Denaturing Elution Buffer, 1X

Catch and Release Capture Tubes

Legal Information

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

signalword

Danger

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 2 - ED ENV 1 - Eye Dam. 1 - Repr. 1B - Skin Corr. 1C


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Neonatal hypoxia-ischemia differentially upregulates MAGUKs and associated proteins in PSD-93-deficient mouse brain
Jiang, X., et al
Stroke, 34, 2958-2963 (2003)
Nan Zhang et al.
Diabetes, 53(4), 963-970 (2004-03-30)
Successful islet transplantation depends on the infusion of sufficiently large quantities of islets, of which only approximately 30% become stably engrafted. Rapid and adequate revascularization of transplanted islets is important for islet survival and function. Delayed and insufficient revascularization can
Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes
Qiao, L., et al
Molecular and cellular biology, 23, 3052-3066 (2003)
Liang-Nian Song et al.
Molecular endocrinology (Baltimore, Md.), 18(1), 70-85 (2003-11-01)
Mifepristone is a potent antagonist of steroid hormone receptors such as glucocorticoid and progesterone receptors. We investigated the potential for mifepristone to act as an antiandrogen and compared it with partial androgen receptor (AR) agonists and antagonists, in particular bicalutamide.
Wanxia He et al.
Journal of virology, 77(19), 10566-10574 (2003-09-13)
Addition of human papillomavirus (HPV) E7 CDK2/cyclin A or CDK2/cyclin E, purified from either insect cells or bacteria, dramatically upregulates histone H1 kinase activity. Activation is substrate specific, with a smaller effect noted for retinoblastoma protein (Rb). The CDK2 stimulatory

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service